Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Convergence of non-communicable diseases and tuberculosis: a two-way street?

Magee MJ, Salindri AD, Gujral UP, Auld SC, Bao J, Haw JS, Lin HH, Kornfeld H.

Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1258-1268. doi: 10.5588/ijtld.18.0045.

PMID:
30355404
2.

Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis.

Auld SC, Gandhi NR, Shah NS.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1113-1114. doi: 10.5588/ijtld.18.0569. No abstract available.

PMID:
30236175
3.

Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities.

Auld SC, Shah NS, Mathema B, Brown TS, Ismail N, Omar SV, Brust JCM, Nelson KN, Allana S, Campbell A, Mlisana K, Moodley P, Gandhi NR.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800246. doi: 10.1183/13993003.00246-2018. Print 2018 Oct.

PMID:
30115614
4.

Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Magee MJ, Salindri AD, Kyaw NTT, Auld SC, Haw JS, Umpierrez GE.

Curr Diab Rep. 2018 Aug 9;18(9):71. doi: 10.1007/s11892-018-1036-y. Review.

PMID:
30090969
5.

Spatial Patterns of Extensively Drug-Resistant Tuberculosis Transmission in KwaZulu-Natal, South Africa.

Nelson KN, Shah NS, Mathema B, Ismail N, Brust JCM, Brown TS, Auld SC, Omar SV, Morris N, Campbell A, Allana S, Moodley P, Mlisana K, Gandhi NR.

J Infect Dis. 2018 Nov 5;218(12):1964-1973. doi: 10.1093/infdis/jiy394.

PMID:
29961879
6.

Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis.

Auld SC, Shah NS, Cohen T, Martinson NA, Gandhi NR.

Respirology. 2018 Jun 5. doi: 10.1111/resp.13333. [Epub ahead of print] Review.

7.

Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?

Auld SC, Kasmar AG, Dowdy DW, Mathema B, Gandhi NR, Churchyard GJ, Rustomjee R, Shah NS.

J Infect Dis. 2017 Nov 3;216(suppl_6):S662-S668. doi: 10.1093/infdis/jix353. Review.

8.

Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Shah NS, Auld SC, Brust JC, Mathema B, Ismail N, Moodley P, Mlisana K, Allana S, Campbell A, Mthiyane T, Morris N, Mpangase P, van der Meulen H, Omar SV, Brown TS, Narechania A, Shaskina E, Kapwata T, Kreiswirth B, Gandhi NR.

N Engl J Med. 2017 Jan 19;376(3):243-253. doi: 10.1056/NEJMoa1604544.

9.

IFN-γ Release Assay Result Is Associated with Disease Site and Death in Active Tuberculosis.

Auld SC, Lee SH, Click ES, Miramontes R, Day CL, Gandhi NR, Heilig CM.

Ann Am Thorac Soc. 2016 Dec;13(12):2151-2158.

10.

Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in Cambodia.

Auld SC, Moore BK, Kyle RP, Eng B, Nong K, Pevzner ES, Eam KK, Eang MT, Killam WP.

Public Health Action. 2016 Jun 21;6(2):129-35. doi: 10.5588/pha.16.0001.

11.

Rollout of Xpert(®) MTB/RIF in Northwest Cambodia for the diagnosis of tuberculosis among PLHA.

Auld SC, Moore BK, Killam WP, Eng B, Nong K, Pevzner EC, Eam KK, Eang MT, Warren D, Whitehead SJ.

Public Health Action. 2014 Dec 21;4(4):216-21. doi: 10.5588/pha.14.0082.

12.

Tuberculin skin test result and risk of death among persons with active TB.

Auld SC, Click ES, Heilig CM, Miramontes R, Cain KP, Bisson GP, Mac Kenzie WR.

PLoS One. 2013 Nov 11;8(11):e78779. doi: 10.1371/journal.pone.0078779. eCollection 2013.

13.

Association between tuberculin skin test result and clinical presentation of tuberculosis disease.

Auld SC, Click ES, Heilig CM, Miramontes R, Cain KP, Bisson GP, Mac Kenzie WR.

BMC Infect Dis. 2013 Oct 4;13:460. doi: 10.1186/1471-2334-13-460.

14.

Reaching beyond our Xpert potential: reflections on the 43rd Union World Conference.

Auld SC, Pevzner E.

Int J Tuberc Lung Dis. 2013 Mar;17(3):423-4. doi: 10.5588/ijtld.13.0023. No abstract available.

PMID:
23407234
15.

Completeness and concordance of TB and HIV surveillance systems for TB-HIV co-infected patients in South Africa.

Auld SC, Kim L, Webb EK, Podewils LJ, Uys M.

Int J Tuberc Lung Dis. 2013 Feb;17(2):186-91. doi: 10.5588/ijtld.12.0530.

PMID:
23317953
16.

Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study.

van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, Abdool Karim Q, Grobler A, Barnabas N, Iriogbe I, Abdool Karim SS; CAPRISA 002 Acute Infection Study Team.

PLoS One. 2008 Apr 16;3(4):e1954. doi: 10.1371/journal.pone.0001954.

17.

Anaemia in acute HIV-1 subtype C infection.

Mlisana K, Auld SC, Grobler A, van Loggerenberg F, Williamson C, Iriogbe I, Sobieszczyk ME, Abdool Karim SS; CAPRISA Acute Infection Study Team.

PLoS One. 2008 Feb 20;3(2):e1626. doi: 10.1371/journal.pone.0001626.

Supplemental Content

Support Center